RBM15B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.062610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.138600E-01
Normal-vs-Stage2
8.964100E-02
Normal-vs-Stage3
1.933680E-02
Normal-vs-Stage4
6.375200E-01
Stage1-vs-Stage2
5.652600E-01
Stage1-vs-Stage3
1.215620E-01
Stage1-vs-Stage4
4.771000E-01
Stage2-vs-Stage3
5.941700E-02
Stage2-vs-Stage4
1.451800E-01
Stage3-vs-Stage4
3.521600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.194040E-01
Normal-vs-AfricanAmerican
1.187010E-01
Normal-vs-Asian
6.366300E-02
Caucasian-vs-AfricanAmerican
8.372400E-01
Caucasian-vs-Asian
4.308600E-01
AfricanAmerican-vs-Asian
4.739800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.306400E-02
Normal-vs-Female
1.703380E-01
Male-vs-Female
4.498000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.643000E-01
Normal-vs-Age(41-60Yrs)
1.384020E-01
Normal-vs-Age(61-80Yrs)
9.980200E-02
Normal-vs-Age(81-100Yrs)
4.916300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.742400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.070000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.780600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.159600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.828800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.112600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.071900E-02
Normal-vs-Daily Drinker
8.039500E-02
Normal-vs-Weekly Drinker
3.269200E-01
Normal-vs-Occasional Drinker
2.056400E-01
Normal-vs-Social Drinker
2.043800E-01
Non Drinker-vs-Daily Drinker
4.165400E-01
Non Drinker-vs-Weekly Drinker
1.033380E-01
Non Drinker-vs-Occasional Drinker
1.309800E-01
Non Drinker-vs-Social Drinker
6.363800E-02
Daily Drinker-vs-Weekly Drinker
3.400400E-01
Daily Drinker-vs-Occasional Drinker
4.513200E-01
Daily Drinker-vs-Social Drinker
2.596800E-01
Weekly Drinker-vs-Occasional Drinker
7.902400E-01
Weekly Drinker-vs-Social Drinker
9.762800E-01
Occasional Drinker-vs-Social Drinker
7.340000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.874400E-01
Normal-vs-Grade 2
9.695400E-01
Normal-vs-Grade 3
9.653000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.624600E-01
Grade 1-vs-Grade 3
7.279200E-01
Grade 1-vs-Grade 4
9.874400E-01
Grade 2-vs-Grade 3
9.063400E-01
Grade 2-vs-Grade 4
9.695400E-01
Grade 3-vs-Grade 4
9.653000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.064040E-01
Normal-vs-NonDiabetic
1.038210E-01
Diabetic-vs-NonDiabetic
3.116000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.871570E-01
Normal-vs-NoPancreatitis
1.122980E-01
Pancreatitis-vs-NoPancreatitis
6.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.146240E-01
Normal-vs-N1
1.040620E-01
N0-vs-N1
9.362400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.635200E-01
Normal-vs-TP53-NonMutant
2.346200E-01
TP53-Mutant-vs-TP53-NonMutant
9.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
